Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

Journal of Clinical Oncology, Vol 22, No 20 (October 15), 2004: pp. 4230-4231
© 2004 American Society of Clinical Oncology.
DOI: 10.1200/JCO.2004.03.147

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kiewe, P.
Right arrow Articles by Thiel, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kiewe, P.
Right arrow Articles by Thiel, E.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

DIAGNOSIS IN ONCOLOGY

Unusual Sites of Hodgkin's Lymphoma

CASE 3. Cholemic Nephrosis in Hodgkin's Lymphoma With Liver Involvement

Philipp Kiewe, Agnieszka Korfel, Christoph Loddenkemper, Lars Fischer, Kristoph Jahnke, Michael Notter, Felix Mühr-Wilkenshoff, Harald Stein, Eckhard Thiel

Charité University Medicine, Campus Benjamin Franklin, Berlin, Germany

A 40-year-old woman presented with fever, night sweats, and a progressive painless jaundice. Medical history included arterial hypertension, hyperlipidemia, and Sjögren's syndrome treated with azathioprine and prednisolone for the previous 6 months. No other drugs were taken.

On examination, liver and spleen were enlarged, but no peripheral lymph nodes were palpable. Abnormal laboratory tests included: hemoglobin 7.9 g/dL (normal range, 12 to 16 g/dL); WBC 3.01/nL (normal range, 4/nL to 10/nL); lymphocytes 3.57% (normal range, 25% to 40%); predominantly conjugated bilirubin 200 µmol/L (normal, < 22 µmol/L); alkaline phosphatase 1,145 U/L (normal, < 104U/L); {gamma}-glutamyl-transferase 168 U/L (normal, < 38 U/L); AST 80 U/L (normal, < 35 U/L); creatinine 152 µmol/L (normal, < 80 µmol/L); urea 18.2 mmol/L (normal, < 8.3 mmol/L); total protein 53 g/L (normal range, 66 to 87 g/L); and albumin 21.5 g/L (normal range, 38 to 51 g/L). Coagulation times were within normal range. Urine analysis revealed urobilinogenuria (68 µmol/L), erythrocyturia (10/µL), and proteinuria (0.25 g/L). Serology for viral hepatitis type A, B, and C was negative. Extrahepatic obstructive cholestasis could be excluded by ultrasound imaging and endoscopic retrograde pancreaticocholangiography. Computed tomography scans of the thorax and abdomen revealed hepatomegaly otherwise inconspicuous, and splenomegaly as well as extensive mediastinal, abdominal, and retroperitoneal lymphadenopathy. A biopsy of the liver showed portal infiltrates of Hodgkin's lymphoma and Reed-Sternberg (HRS) cells in a background rich in eosinophils (Fig 1A). HRS cells were marked by a strong expression of CD30 (Fig 1B), and the Epstein-Barr virus–encoded latent membrane protein 1 (LMP1; not shown). Infiltration with HRS cells was also detected in bone marrow biopsy, which otherwise showed dysplastic features presumably related to preceeding azathioprine treatment. During the following few days, bilirubin had risen to 520 µmol/L, prothrombin time increased, anemia worsened, and thrombocytopenia developed. Renal function deteriorated; eventually, hyperkalemia developed, and hemodialysis was begun and carried out every other day. While ultrasound morphology of the kidney was normal, a fine-needle biopsy showed multiple greenish bile casts in the renal tubules, with degenerative changes of the tubular cells but no evidence of lymphoma cells (Fig 2), yielding the diagnosis of acute renal failure due to cholemic nephrosis. After chemotherapy with dose-reduced doxorubicin, bleomycin, vinblastine, dacarbazine (ABVD) regimen, cholestatic parameters and liver function rapidly improved along with renal function restoration, so that hemodialysis could be discontinued.



View larger version (72K):
[in this window]
[in a new window]
 
Fig 1.
 


View larger version (132K):
[in this window]
[in a new window]
 
Fig 2.
 
While hepatic involvement is seen in approximately 5% to 14% of newly diagnosed cases of Hodgkin's lymphoma, clinical jaundice is uncommon.1 Whereas renal complications occur in lymphomas, particularly in Hodgkin's lymphoma, the morphological correlate is usually a glomerular lesion—most commonly, minimal-change disease or focal segmental glomerulosclerosis.2 Cholemic nephrosis due to an excessive elevation of serum bilirubin leading to acute renal failure is a rare event, and to our knowledge, has not been reported. Proximal tubular dysfunction to a certain degree is evident in all patients with obstructive jaundice.3 Impaired cellular pH regulation and oxidative damage of tubular epithelium caused by bile acids have been proposed as contributory factors.4 The histologic findings are hypertrophy or degeneration of tubular epithelium, and bile-stained casts occupying collecting and distal convoluted tubules. After prolonged jaundice, alterations can also be noticed in the epithelium lining the Bowman's capsule.5 The lesions of cholemic nephrosis are reported to be reversible to a point, provided that the cholestatic process ceases.6 While there is a correlation to the duration of jaundice5 and the serum bilirubin level, a threshold for serum bilirubin levels is not known.3 In our case, the findings of renal biopsy were consistent with cholemic nephrosis; Sjögren's syndrome–and Hodgkin's lymphoma–associated nephropathy were ruled out. Due to immediate treatment of Hodgkin's lymphoma, hepatic and renal function were restored.

Authors' Disclosures of Potential Conflicts of Interest
The authors indicated no potential conflicts of interest.

REFERENCES

1. Cervantes F, Briones J, Bruguera M, et al: Hodgkin's disease presenting as a cholestatic febrile illness: Incidence and main characteristics in a series of 421 patients. Ann Hematol 72:357-360, 1996[Medline]

2. Dabbs DJ, Morel-Maroger Striker L, Mignon F, et al: Glomerular lesions in lymphomas and leukemias. Am J Med 80:63-70, 1986[CrossRef][Medline]

3. Bairaktari E, Liamis G, Tsolas O, et al: Partially reversible renal tubular damage in patients with obstructive jaundice. Hepatology 33:1365-1369, 2001[CrossRef][Medline]

4. Bomzon A, Holt S, Moore K: Bile acids, oxidative stress, and renal function in biliary obstruction. Semin Nephrol 17:549-562, 1997[Medline]

5. Holmes TW Jr: The histologic lesion of cholemic nephrosis. J Urol 70:677-685, 1953[Medline]

6. Thompson LL, Frazier WD, Ravdin IS: The renal lesion in obstructive jaundice. Am J Med Sc 199:305, 1940


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?



This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kiewe, P.
Right arrow Articles by Thiel, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kiewe, P.
Right arrow Articles by Thiel, E.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2004 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online